EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Outcomes reported in randomized controlled trials for mixed and non‐IgE‐mediated food allergy: Systematic review

Manal Bel Imam iD, Charalampos-Vlasios Stikas iD, Payal Guha iD, Bo L Chawes, Derek Chu iD, Matthew Greenhawt iD, Ekaterina Khaleva, Daniel Munblit iD, Nikita Nekliudov iD, Willem van de Veen, Ann-Marie M Schoos iD, Core Outcome Measures for Food Allergy (COMFA) consortium

Clinical & Experimental Allergy · 2023

DOI: 10.1111/cea.14304 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical & Experimental Allergy, 2023. Verfasst von Manal Bel Imam und 11 weiteren Autor:innen. Beteiligte Einrichtung: Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland. Hauptthemen laut MEDLINE: Food Hypersensitivity, Eosinophilic Esophagitis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mixed and non‐IgE‐mediated food allergy is a subset of immune‐mediated adverse food reactions that can impose a major burden on the quality of life of affected patients and their families. Clinical trials to study these diseases are reliant upon consistent and valid outcome measures that are relevant to both patients and clinicians, but the degree to which such stringent outcome reporting takes place is poorly studied.

Objective

As part of the Core Outcome Measures for Food Allergy (COMFA) project, we identified outcomes reported in randomized clinical trials (RCT) of treatments for mixed or non‐IgE‐mediated food allergy.

Design

In this systematic review, we searched the Ovid, MEDLINE and Embase databases for RCTs in children or adults investigating treatments for food protein‐induced enterocolitis syndrome, food protein‐induced allergic proctocolitis, food protein‐induced enteropathy and eosinophilic gastrointestinal disorders including eosinophilic esophagitis [EoE], eosinophilic gastritis and eosinophilic colitis published until 14 October 2022.

Results

Twenty‐six eligible studies were identified, with 23 focused on EoE (88%). Most interventions were corticosteroids or monoclonal antibodies. All EoE studies assessed patient‐reported dysphagia, usually using a non‐validated questionnaire. Twenty‐two of 23 EoE studies used peak tissue eosinophil count as the primary outcome, usually using a non‐validated assessment method, and other immunological markers were only exploratory. Thirteen (57%) EoE studies reported endoscopic outcomes of which six used a validated scoring tool recently recommended as a core outcome for EoE trials. Funding source was not obviously associated with likelihood of an RCT reporting mechanistic versus patient‐reported outcomes. Only 3 (12%) RCTs concerned forms of food allergy other than EoE, and they reported on fecal immunological markers and patient‐reported outcomes.

Conclusions

Outcomes measured in clinical trials of EoE and non‐IgE‐mediated food allergy are heterogeneous and largely non‐validated. Core outcomes for EoE have been developed and need to be used in future trials. For other forms of mixed or non‐IgE‐mediated food allergies, core outcome development is needed to support the development of effective treatments.

Systematic review registration

OSF public registry DOI: 10.17605/OSF.IO/AZX8S

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Food HypersensitivityEosinophilic EsophagitisGastritisChildFoodHumansEnteritisAdultRandomized Controlled Trials as TopicEosinophilia

Stichwörter der Autor:innen

eosinophilic esophagitisfood protein-induced allergic proctocolitisfood protein-induced enterocolitis syndromefood protein-induced enteropathynon-IgE-mediated food allergyoutcome measures

Autor:innen und Institutionen

  • Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
  • School of Medicine, Imperial College London, London, UK.
  • COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • The Research Institute of St Joe's Hamilton, Hamilton, Ontario, Canada.

ORCID-Profile: Manal Bel Imam, Charalampos-Vlasios Stikas, Payal Guha, Derek Chu, Matthew Greenhawt, Daniel Munblit, Nikita Nekliudov, Ann-Marie M Schoos

Zitieren

APA

Bel Imam, M., Stikas, C. V., Guha, P., Chawes, B. L., Chu, D., Greenhawt, M., Khaleva, E., Munblit, D., Nekliudov, N., van de Veen, W., Schoos, A. M., & Core Outcome Measures for Food Allergy (COMFA) consortium (2023). Outcomes reported in randomized controlled trials for mixed and non‐IgE‐mediated food allergy: Systematic review. Clinical & Experimental Allergy. https://doi.org/10.1111/cea.14304

Vancouver

Bel Imam M, Stikas CV, Guha P, Chawes BL, Chu D, Greenhawt M, et al. Outcomes reported in randomized controlled trials for mixed and non‐IgE‐mediated food allergy: Systematic review. Clinical & Experimental Allergy. 2023. doi:10.1111/cea.14304

BibTeX
@article{BelImam2023,
  author = {Bel Imam, Manal and Stikas, Charalampos-Vlasios and Guha, Payal and Chawes, Bo L and Chu, Derek and Greenhawt, Matthew and Khaleva, Ekaterina and Munblit, Daniel and Nekliudov, Nikita and van de Veen, Willem and Schoos, Ann-Marie M and Core Outcome Measures for Food Allergy (COMFA) consortium, Core Outcome Measures for Food Allergy (COMFA) consortium},
  title = {Outcomes reported in randomized controlled trials for mixed and non‐IgE‐mediated food allergy: Systematic review},
  journal = {Clinical & Experimental Allergy},
  year = {2023},
  doi = {10.1111/cea.14304}
}
Kostenlos starten →